|
XalatanDrug - Xalatan The trade name of the product as shown on the labeling.
Dosage -
SOLUTION/DROPS; OPHTHALMIC
Active Ingredient(s) -
Latanoprost
Strength -
0.005%
Applicant -
PHARMACIA AND UPJOHN
New Drug Application (NDA) Number -
020597
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Jun 5, 1996
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Pharmacia And Upjohn Co
Xalatan
Prevacid 15mg Tablet, Delayed Release, Orally Disintegrating; Oral
Prevacid 30mg Tablet, Delayed Release, Orally Disintegrating; Oral Naprapac 250 (copackaged) 15mg,n/a;n/a,250mg Capsule, Delayed Rel Pellets; Tablet; Oral Naprapac 375 (copackaged) 15mg,n/a;n/a,375mg Capsule, Delayed Rel Pellets; Tablet; Oral Naprapac 500 (copackaged) 15mg,n/a;n/a,500mg Capsule, Delayed Rel Pellets; Tablet; Oral Fosrenol Eq 250mg Base Tablet, Chewable; Oral Fosrenol Eq 500mg Base Tablet, Chewable; Oral Xalatan 0.005% Solution/drops; Ophthalmic Prevacid 30mg/packet For Suspension, Delayed Release; Oral Prevacid Iv 30mg/vial Injectable; Intravenous NewDrugInformation |